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Abstract Peroxisome assembly in mammals requires more than
15 genes. Two isoforms of the peroxisome targeting signal type 1
(PTS1) receptor, Pex5pS and Pex5pL, are identified in
mammals. Pex5pS and Pex5pL bind PTS1 proteins. Pex5pL,
but not Pex5pS, directly interacts with the PTS2 receptor,
Pex7p, carrying its cargo PTS2 protein in the cytosol. Pex5p
carrying the cargos, PTS1 and PTS2, docks with the initial site
Pex14p in a putative import machinery, subsequently translocat-
ing to other components such as Pex13p, Pex2p, Pex10p and
Pex12p, whereby the matrix proteins are imported. The
peroxins, Pex3p, Pex16p and Pex19p, function in the assembly
of peroxisomal membrane vesicles that precedes the import of
matrix proteins. Hence, peroxisomes may form de novo and do
not have to arise from pre-existing, morphologically recognizable
peroxisomes. Impaired peroxisome assembly causes peroxisome
biogenesis disorders such as Zellweger syndrome. ß 2000 Fed-
eration of European Biochemical Societies. Published by Else-
vier Science B.V. All rights reserved.
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1. Introduction
Peroxisomes are present in a wide variety of eukaryotic
cells, from yeast to humans, and they function in various
metabolic pathways, including the L-oxidation of very long
chain fatty acids and the synthesis of ether-lipids [1]. Peroxi-
somal proteins, including membrane proteins, are encoded by
nuclear genes and are translated on free polyribosomes in the
cytosol [2]. Peroxisomes are thought to be formed by the
division of pre-existing peroxisomes after the import of newly
synthesized proteins [2]. Genetic analyses of peroxisome bio-
genesis-defective mutants of yeast and mammalian cells have
led to the identi¢cation of a number of protein factors, termed
peroxins, which are essential for peroxisome assembly [3^7].
The functional consequence of human peroxisomes is high-
lighted by fatal genetic peroxisome biogenesis disorders
(PBDs), including Zellweger syndrome, neonatal adrenoleuko-
dystrophy, infantile Refsum disease and rhizomelic chondro-
dysplasia puntata, all of which are linked to a failure of per-
oxisome biogenesis [4^8]. Genetic heterogeneity comprising
more than 15 complementation groups (CGs) has been iden-
ti¢ed in mammals, by CG analysis using ¢broblasts from pa-
tients with PBD and peroxisome-de¢cient Chinese hamster
ovary (CHO) cell mutants [9,10]. Therefore, more than 15
genes are likely to be involved in mammalian peroxisome bio-
genesis.
Mechanisms of peroxisome assembly, including peroxisom-
al import of newly synthesized proteins, are one of the major
foci in peroxisome research. Studies on both peroxisome bio-
genesis and PBDs at the molecular level are rapidly progress-
ing. The identi¢cation and characterization of numerous genes
that are essential for peroxisome biogenesis, by means of the
genetic phenotype-complementation of peroxisome assembly-
defective mutants of mammalian somatic cells such as CHO
cells and of several yeast species including Saccharomyces ce-
revisiae, Pichia pastoris, Hansenula polymorpha and Yarrowia
lipolytica, have made invaluable contributions to the study of
peroxisome biogenesis [4^7] and protein tra⁄cking in eukary-
otes [11]. I herein summarize recent ¢ndings on peroxisome
biogenesis factors involved in matrix protein import and
membrane assembly in mammals and pathogenic genes re-
sponsible for PBDs.
2. Genetic approaches to studying mammalian peroxisome
biogenesis
Two mutually distinct but complementary approaches have
been taken in order to isolate mammalian peroxin genes.
2.1. Isolation of peroxisome-de¢cient mammalian cell mutants
Two methods have been developed for the isolation of
mammalian somatic cell mutants defective in peroxisome bio-
genesis : (i) colony autoradiographic screening with a pheno-
typic marker, dihydroxyacetonephosphate acyltransferase de-
¢ciency [12,13] and (ii) the photo-sensitized selection method
using 9-(1P-pyrene)nonanol and an exposure to long wave-
length ultraviolet (UV) light [14]. Using these two methods,
we have so far isolated 13 CGs of peroxisome-de¢cient CHO
cell mutants [4,10,15^17]. All CHO cell mutants showed a
phenotype of de¢ciency in peroxisome biogenesis, as noted
in ¢broblasts from PBD patients [13,18,19]. Peroxisomal rem-
nants, called membrane ghosts, are seen in most CHO mu-
tants [4], except for ZP119 [15] and ZPG208 [10], as reported
for ¢broblasts from peroxisome-de¢cient PBD patients [20]. A
complete set of CG analyses by cell fusion between 13 CGs of
CHO cell mutants and 13 CGs of ¢broblasts from patients
with PBDs revealed that nine CGs of CHO mutants represent
the human PBD CGs (Table 1) [10,15^18]. CHO mutants,
ZP110, ZP114, ZP126 and ZPG208, were distinct from any
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of the 13 human CGs. Accordingly, peroxisome assembly ap-
parently requires at least 17 gene products in mammals, in-
cluding humans.
2.2. Genes required for peroxisome biogenesis
2.2.1. Genetic phenotype-complementation assay. Nine per-
oxin cDNAs, PEX1, PEX2 (formerly PAF-1), PEX3, PEX5,
PEX6, PEX12, PEX13, PEX14 and PEX19, have been cloned
by functional phenotype-complementation assay on CHO cell
mutants [17,21^29] (Fig. 1). We also showed most of these
PEXs to be responsible for human PBDs [17,21,24,26,27,29^
32] (Table 1).
2.2.2. Expressed sequence tag (EST) homology search. An
alternative strategy, i.e. the homology search by screening the
EST database using yeast PEX genes, has successfully led to
the isolation of human orthologue genes responsible for
PBDs: PEX1 [33,34], PEX5 [35], PEX6 [36], PEX7 [37^39],
PEX10 [40,41], PEX12 [42] and PEX16 [43,44].
3. Biogenesis of peroxisomes
3.1. Import of matrix proteins and import machinery
The import of most peroxisomal matrix proteins is medi-
ated by two types of cis-acting peroxisomal targeting signals
(PTSs): the C-terminal uncleavable tripeptide PTS1, -S/A/C-
K/R/H-L/(M) [45,46], and the nonapeptide presequence PTS2,
-(R/K)(L/V/I)X5(H/Q)(L/A)-, located at the N-terminus
[47,48]. PEX5 and PEX7 encode the receptors for PTS1 and
PTS2, respectively. A de¢ciency of Pex5p, a member of the
tetratricopeptide repeat family, causes PBDs of CG2 manifest-
ing protein import defects [24,35,49] (Table 1). Dysfunction of
Pex7p is responsible for CG11 RCDP showing a cell pheno-
type of impaired PTS2 import [37^39].
Two phenotypically distinct groups of PEX5-defective CG2
CHO cell mutants were isolated [24]. One group of pex5 CHO
mutants such as ZP105 showed the import defect of both
PTS1 and PTS2 proteins, whilst another group represented
by ZP139 was impaired in the transport of PTS1 proteins
but not of PTS2 proteins, exactly as in yeast pex5 mutants.
Fibroblasts with such distinct phenotypes from patients of
CG2 were also identi¢ed [35,50]. In mammals, including the
Chinese hamster and humans, two isoforms of Pex5p termed
Pex5pS and Pex5pL with an internal 37 amino acid insertion
have been identi¢ed [24,50], whilst in yeast only a single type
of Pex5p was isolated [5,6]. Pex5pS and Pex5pL form a ho-
momeric as well as heteromeric dimer [51]. The expression of
either type of Pex5p complemented the impaired PTS1 import
in CHO pex5 mutants as in yeast, but only Pex5pL could
rescue the PTS2 import defect noted in a subgroup such as
ZP105 [24]. Likewise, only Pex5pL can restore PTS2 import in
¢broblasts from a CG2 patient with Zellweger syndrome [50].
We recently found that Pex5pL directly interacts with the
PTS2 receptor, Pex7p, carrying its cargo PTS2 protein in
the cytosol [51,52]. Pex5pL, but not Pex5pS, translocates the
Pex7p and PTS2 protein complex to peroxisomes. Further-
more, a recently isolated pex5 mutant cell line, ZPG231,
showed a novel phenotype, PEX5-defective but impaired sole-
ly in the PTS2 import [52]. The missense point mutation,
Ser214Phe, in the PEX5 gene disrupted the interaction of
Pex5pL with Pex7p, resulting in complete elimination of the
PTS2 import pathway. Therefore, it is evident that Pex5pL
plays an exclusively pivotal role in PTS2 transport, in addition
to PTS1 import.
Mammalian PEX14 encoding a 41 kDa protein was isolated
by functional complementation of a CHO mutant, ZP110 [28]
or by an EST search using a yeast gene [53,54]. Pex14p was
characterized as an integral membrane protein of peroxi-
somes, exposing its N- and C-terminal parts to the cytosol
[28]. Pex5p is localized mostly in the cytosol in the wild-type
CHO-K1 and Pex14p-de¢cient mutant cells, whilst it accumu-
lates to the peroxisomal remnants in cell mutants defective of
Pex13p and the RING family peroxins such as Pex2p and
Pex12p [51]. Furthermore, overexpression of Pex14p [28],
but not Pex10p [40], Pex12p [27] or Pex13p [17], causes accu-
mulation of Pex5p to peroxisomal membranes, with concom-
itant interference with the PTS1 and PTS2 import [51]. There-
fore, the import of PTS1 and PTS2 possibly shares the
common, if not exclusive, translocon, as inferred from the
common phenotype, the impaired import of both PTS1 and
PTS2, in mammalian cell mutants, pex2, pex10, pex12, pex13
Table 1
CGs and complementing genes of peroxisome de¢ciency
Fibroblasts Phenotypea CHO mutants Complementing gene
Japan USA/Europe
A 8 ZS, NALD, IRD ZP124
B 7 (5) ZS, NALD PEX10
C 4 ZS, NALD ZP92 PEX6
D 9 ZS PEX16
E 7 ZS, NALD, IRD Z24, ZP107 PEX1
F 10 ZS, IRD Z65 PEX2 (PAF-1)
2 ZS, NALD ZP105, ZP139 PEX5
3 ZS ZP109 PEX12
6 ZS, NALD
G ZS
H ZS, NALD ZP128 PEX13
J ZS ZP119 PEX19





aZS, Zellweger syndrome; NALD, neonatal adrenoleukodystrophy; IRD, infantile Refsum disease; RCDP, rhizomelic chondrodysplasia puncta-
ta.
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and pex14. Collectively, these ¢ndings demonstrate that a
mobile shuttle signal-receptor Pex5p, carrying the cargos
PTS1 as well as Pex7p-PTS2 proteins, most likely docks
with the initial site Pex14p in a potential machinery for the
import of matrix proteins and subsequently translocates to
other machinery-components such as Pex13p, Pex2p, Pex10p
and Pex12p (Fig. 1). After unloading the cargos, Pex5p and
Pex7p, in a bound form or independently, cycle back to the
cytosol. In contrast to the mammalian system, in yeast Pex5p-
PTS1 proteins and Pex7p-PTS2 polypeptides independently
bind to Pex14p [55].
3.2. Membrane assembly
Three mammalian peroxins, Pex3p, Pex16p and Pex19p,
have been isolated either by functional phenotype-comple-
mentation assay on CHO cell mutants [23,29] or by the EST
database search using yeast PEX genes [43,44,56,57] and
shown to be essential for peroxisome membrane assembly.
3.2.1. Pex19p. PEX19 encodes a farnesylated protein par-
tially, if not completely, anchored to peroxisome membranes
[29,58]. Pex19p is identical to the previously isolated PxF [59].
HsPEX19 expression complemented impaired peroxisome bio-
genesis in ¢broblasts from a patient with CG-J PBD [29]. This
patient possessed a homozygous, inactivating mutation: a
one-base insertion, 764A, in a codon for 255Met resulted in a
frameshift, inducing a 24 amino acid sequence entirely distinct
from normal Pex19p. Upon transfection of HsPEX19 into a
CHO pex19 mutant ZP119 devoid of peroxisomal ‘ghosts’
[15], the most striking was the formation of peroxisomal mem-
branes followed by the import of matrix proteins [29]. This
was the ¢rst observation of the membrane assembly process
during peroxisome biogenesis, particularly di¡erentiated from
the import of soluble proteins.
3.2.2. Pex16p. HsPEX16 encoding a 336 amino acid per-
oxisomal protein was isolated by the EST homology search
using Y. lipolytica PEX16 [43,44]. Fibroblasts from a Zell-
weger patient of CG-D (the same group as CG9 in USA)
are defective in peroxisomal membrane biogenesis and mor-
phologically devoid of peroxisomal remnants, as in PEX19-
defective ¢broblasts of CG-J [9,29]. HsPEX16 expression re-
stored peroxisomal membrane assembly and matrix protein
import in CG-D ¢broblasts [43]. Membrane biogenesis appar-
ently precedes the import of soluble proteins [44] (Honsho and
Fujiki, unpublished observation). The mutation, Arg176Ter,
in PEX16 was identi¢ed as the genetic cause of CG-D PBD.
3.3.3. Pex3p. Pex3p expression re-established peroxisome
Fig. 1. A schematic view of peroxisome biogenesis in mammals. The intracellular locations and molecular properties of peroxins so far identi-
¢ed are shown. Peroxins are divided into four groups: (i) peroxins that are required for matrix protein import; (ii) those including Pex3p,
Pex16p and Pex19p, responsible for peroxisome membrane assembly; (iii) those such as Pex1p and Pex6p of the AAA family presumably in-
volved in membrane fusion step and (iv) those such as Pex11p apparently involved in proliferation. Import of matrix proteins has been better
understood: matrix proteins, PTS1 and PTS2 proteins, are recognized by Pex5p and Pex7p, respectively. Two isoforms of Pex5p are identi¢ed
in mammals. PTS1 proteins are transported by Pex5pS and Pex5pL to peroxisomes, where Pex14p functions as a convergent component of
‘protein import machinery’ (for details, see text). Pex5pL directly interacts with the PTS2 receptor, Pex7p, carrying its cargo PTS2 protein in
the cytosol and translocates the Pex7p-PTS2 protein complex to the initial docking site Pex14p. Pex5p carrying the cargos subsequently translo-
cates to other components such as Pex13p, Pex2p, Pex10p and Pex12p. PTS1 and PTS2 proteins are then released at the inner surface and/or
inside of peroxisomes. Both Pex5p and Pex7p ¢nally shuttle back to the cytosol.
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formation in pex3 mutants from CHO cells [10,23] and yeasts,
H. polymorpha [60] and P. pastoris [61], all absent from per-
oxisomal membrane structures. Upon expression of PEX3 in a
CHO pex3 mutant ZPG208, peroxisomal membrane vesicles
were assembled prior to the import of soluble proteins such as
PTS1 and PTS2 proteins [23], as in pex19 [29] and pex16
[43,44] cell mutants, implying the temporally di¡erentiated
translocation of matrix proteins into peroxisomal membrane
vesicles. Pex3p was characterized as an integral membrane
protein of peroxisomes, exposing its N- and C-terminal parts
to the cytosol [23]. A homozygous, inactivating missense mu-
tation, G to A at position 413 in a codon (GGA) for 138Gly
resulting in a codon (GAA) for Glu, was the genetic cause of
peroxisome de¢ciency of pex3 ZPG208 [23]. The peroxisome-
restoring activity apparently required the full length of Pex3p,
while its N-terminal part from residues 1 to 40 was su⁄cient
to target a fusion protein to peroxisomes [23].
Collectively, Pex3p, Pex16p and Pex19p can be categorized
as peroxins essential for the assembly of peroxisome mem-
branes. They may function as essential factors required for
the translocation process of membrane proteins and/or mem-
brane vesicle assembly, possibly in a concerted manner. Pex3p
indeed interacts with Pex19p, both in vivo and in vitro [23], as
recently found in S. cerevisiae [58] and P. pastoris [62], as well
as in human cells [57]. Pex3p may function in peroxisomal
membrane assembly at an early stage by interacting with
Pex19p but not with Pex16p. However, it is not clear whether
or not Pex3p is a prerequisite peroxin for Pex19p to be local-
ized to and/or anchored on peroxisomal membranes. Pex3p
does not appear to require Pex19p for targeting in mammals
[23] and may function upstream of Pex19p as noted in P.
pastoris [62]. It is also noteworthy that Pex3p and Pex19p
were very recently suggested to play a role in recognizing
newly synthesized membrane proteins and transporting them
to ‘preperoxisome’ vesicles [63,64]. Taken together, peroxi-
somes may form de novo and do not have to arise from
pre-existing, morphologically recognizable peroxisomes. At
such an early stage of peroxisome assembly the endoplasmic
reticulum (ER) may be involved, as was suggested for Pex2p
and Pex16p, both initially residing in ER in Y. lipolytica [65].
However, no direct evidence for the involvement of ER in
peroxisome assembly has been noted in mammalian cells.
The assembled membrane vesicles then import other mem-
brane components, including those of a potential matrix pro-
tein import machinery such as Pex14p, Pex13p and the RING
family peroxins, to form ‘premature peroxisomes’ which are
capable of importing matrix proteins. The matured peroxi-
somes ¢nally divide so that progeny peroxisomes emerge.
4. Perspective
More than 15 CGs of mammalian cell mutants have been
identi¢ed, including PBD patients’ ¢broblasts and CHO mu-
tant cell lines [10]. Pathogenic genes have been elucidated for
most of the PBD CGs and only a few are as yet unidenti¢ed.
The biochemical functions of several peroxins involved in the
import of matrix proteins have been better elucidated. How-
ever, the molecular mechanisms by which most of the perox-
ins function in peroxisome biogenesis, particularly in mem-
brane assembly, remain to be addressed. Future
investigations using the cloned peroxins and pex mutants in-
cluding PEX gene-knock-out mice [66,67], will shed light on
the mechanisms involved in peroxisome biogenesis and the
pathogenesis of PBD.
5. Note
I apologize for not citing all invaluable papers recently con-
tributed owing to the limitation of space.
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